President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

After posting a double beat for Q2 2025, J&J (NYSE:JNJ), the pharma sector’s bellwether for the earnings season, added ~6% on ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

The measure raises taxes on the endowments of the nation's largest universities but not those of private charitable ...

Trump on Tuesday predicted that he could strike “two or three” trade deals with countries before implementing his so-called ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...

President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.

The U.S. President said the tariff rate for pharmaceuticals could be as much as 200 per cent, but wouldn’t kick in for about ...

Trump’s threat to slap a 200% tariff on pharmaceutical imports, made offhandedly at a cabinet meeting, has sparked a selloff in some drug stocks, but analysts say the number may be more political ...